omniture
logo
Search
ZHEJIANG VIMGREEN PHARMACEUTICALS, LTD
Media Room

Latest News

rss

Vimgreen's Novel A2AR Antagonist Receives CDE IND Approval for NASH/MASH Therapy

HANGZHOU, China, March 14, 2026 /PRNewswire/ -- Vimgreen Pharmaceuticals, a leading innovator in ad...

2026-03-14 12:33 4251

Vimgreen Completes Enrollment of Its Phase 2 Clinical Trial Evaluating VG081821AC for the Treatment of Parkinson's Disease

HANGZHOU, China, Aug. 15, 2024 /PRNewswire/ -- Vimgreen Pharmaceuticals, a science-driven pharmaceu...

2024-08-15 21:37 3715